Omega-3 acid ethyl esters (USP) 1000 MG Oral Capsule — RxCUI 577208
RxNorm drug concept · Semantic clinical drug
RxCUI 577208
Semantic clinical drug · SCD
● Current RxNorm concept 25 FDA products
35 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI577208
Official nameOmega-3 acid ethyl esters (USP) 1000 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asomega-3 acid ethyl esters 1 GM (at least 900 MG) Oral Capsule; omega-3 acid ethyl esters 1 GM Oral Capsule
FDA products mapped25
Package NDCs mapped35
Reported Medicaid activity (SDUD)437,338 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Omega-3-Acid Ethyl Esters: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- This medication is specifically approved for adults with severely high triglyceride levels — 500 mg/dL or above. It's a prescription-strength omega-3 fatty acid, quite different fr...
- What exactly is this medication for? My doctor said my triglycerides were very high.
- Prescription omega-3-acid ethyl esters like Lovaza are not the same as over-the-counter fish oil. They contain standardized, concentrated amounts of EPA and DHA and have been teste...
- Can I just take regular fish oil from the store instead?
🕸️ Concept Web — How Omega-3 acid ethyl esters (USP) 1000 MG Oral Cap... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Omega-3 acid ethyl esters (USP) 1000 MG Oral Capsule
RxCUI 577208 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Omega-3 acid ethyl esters (USP)
484348IN
-
Omega-3 acid ethyl esters (USP)
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lovaza
278346BN
-
Lovaza
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Omega-3 acid ethyl esters (USP) Oral Capsule
809886SCDF -
Omega-3 acid ethyl esters (USP) Oral Product
1161021SCDG -
Omega-3 acid ethyl esters (USP) Pill
1161022SCDG -
Omega-3 acid ethyl esters (USP) Oral Capsule [Lovaza]
809887SBDF -
Lovaza Oral Product
1180928SBDG -
Lovaza Pill
1180929SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Omega-3 acid ethyl esters (USP) Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Omega-3 acid ethyl esters (USP) 1000 MG
577206SCDC -
Omega-3 acid ethyl esters (USP) 1000 MG Oral Capsule [Lovaza]
607044SBD -
Omega-3 acid ethyl esters (USP) 1000 MG [Lovaza]
607042SBDC
-
Omega-3 acid ethyl esters (USP) 1000 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Omega-3 acid ethyl esters (USP) 1000 MG
SCDC · 577206 -
Omega-3 acid ethyl esters (USP) Oral Capsule
SCDF · 809886 -
Omega-3 acid ethyl esters (USP) Oral Product
SCDG · 1161021 -
Omega-3 acid ethyl esters (USP) Pill
SCDG · 1161022
Brand-Name Concepts
-
Omega-3 acid ethyl esters (USP) 1000 MG Oral Capsule [Lovaza]
SBD · 607044 -
Omega-3 acid ethyl esters (USP) 1000 MG [Lovaza]
SBDC · 607042 -
Omega-3 acid ethyl esters (USP) Oral Capsule [Lovaza]
SBDF · 809887 -
Lovaza Oral Product
SBDG · 1180928 -
Lovaza Pill
SBDG · 1180929 -
Lovaza
BN · 278346
📦 FDA Products & Package NDCs
25 products · 35 package NDCs
35 package NDCs map to RxCUI 577208 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00254-3010-08 | 120 CAPSULE in 1 BOTTLE (0254-3010-08) | Omega-3-acid ethyl esters | Par Pharmaceutical Inc. | 2017-09-19 |
| 00615-8550-39 | 30 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0615-8550-39) | OMEGA-3-ACID ETHYL ESTERS | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-10-15 |
| 00904-7495-06 | 50 BLISTER PACK in 1 CARTON (0904-7495-06) / 1 CAPSULE, LIQ... | OMEGA-3-ACID ETHYL ESTERS | Major Pharmaceuticals | 2024-12-13 |
| 24658-0350-12 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (24658-350-12) | OMEGA-3-ACID ETHYL ESTERS | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 2023-08-22 |
| 31722-0936-05 | 500 CAPSULE, LIQUID FILLED in 1 BOTTLE (31722-936-05) | Omega-3-acid ethyl esters | Camber Pharmaceuticals, Inc. | 2019-02-25 |
| 31722-0936-12 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (31722-936-12) | Omega-3-acid ethyl esters | Camber Pharmaceuticals, Inc. | 2019-02-25 |
| 42806-0552-12 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (42806-552-12) | OMEGA-3-ACID ETHYL ESTERS | EPIC PHARMA, LLC | 2020-07-02 |
| 50090-5799-00 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (50090-5799-0) | Omega-3-acid ethyl esters | A-S Medication Solutions | 2021-10-14 |
| 50090-5800-02 | 1440 CAPSULE, LIQUID FILLED in 1 BOTTLE (50090-5800-2) | Omega-3-acid ethyl esters | A-S Medication Solutions | 2022-01-25 |
| 50090-6691-00 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (50090-6691-0) | OMEGA-3-ACID ETHYL ESTERS | A-S Medication Solutions | 2023-09-18 |
| 50090-6692-00 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (50090-6692-0) | OMEGA-3-ACID ETHYL ESTERS | A-S Medication Solutions | 2023-09-18 |
| 50090-6822-00 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (50090-6822-0) | Omega-3-acid ethyl esters | A-S Medication Solutions | 2024-01-04 |
| 51407-0763-12 | 120 CAPSULE in 1 BOTTLE, PLASTIC (51407-763-12) | Omega-3-Acid Ethyl Esters | Golden State Medical Supply, Inc. | 2023-12-19 |
| 60687-0846-65 | 50 BLISTER PACK in 1 CARTON (60687-846-65) / 1 CAPSULE in 1... | omega-3-acid ethyl esters | American Health Packaging | 2025-04-29 |
| 62135-0780-12 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (62135-780-12) | omega-3-acid ethyl esters | Chartwell RX, LLC | 2023-10-10 |
| 63629-1918-01 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (63629-1918-1) | Omega-3-acid ethyl esters | Bryant Ranch Prepack | 2019-02-25 |
| 64380-0761-02 | 5 BLISTER PACK in 1 CARTON (64380-761-02) / 10 CAPSULE in 1... | omega-3-acid ethyl esters | Strides Pharma Science Limited | 2026-05-29 |
| 64380-0761-11 | 120 CAPSULE in 1 BOTTLE (64380-761-11) | omega-3-acid ethyl esters | Strides Pharma Science Limited | 2026-05-29 |
| 69452-0175-17 | 60 CAPSULE, LIQUID FILLED in 1 BOTTLE (69452-175-17) | Omega-3-Acid Ethyl Ester | Bionpharma Inc. | 2017-01-15 |
| 69452-0175-22 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (69452-175-22) | Omega-3-Acid Ethyl Ester | Bionpharma Inc. | 2017-01-15 |
| 70518-3040-00 | 180 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (70518-3040-... | OMEGA-3-ACID ETHYL ESTERS | REMEDYREPACK INC. | 2021-03-04 |
| 70518-3040-01 | 50 POUCH in 1 BOX (70518-3040-1) / 1 CAPSULE, LIQUID FILLED... | OMEGA-3-ACID ETHYL ESTERS | REMEDYREPACK INC. | 2026-04-25 |
| 70756-0423-22 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (70756-423-22) | OMEGA-3-ACID ETHYL ESTERS | Lifestar Pharma LLC | 2021-11-16 |
| 71335-2024-01 | 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (71335-2024-1) | OMEGA-3-ACID ETHYL ESTERS | Bryant Ranch Prepack | 2022-01-10 |
| 71335-2024-02 | 28 CAPSULE, LIQUID FILLED in 1 BOTTLE (71335-2024-2) | OMEGA-3-ACID ETHYL ESTERS | Bryant Ranch Prepack | 2022-01-10 |
| 71335-2024-03 | 60 CAPSULE, LIQUID FILLED in 1 BOTTLE (71335-2024-3) | OMEGA-3-ACID ETHYL ESTERS | Bryant Ranch Prepack | 2022-01-10 |
| 71335-2024-04 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (71335-2024-4) | OMEGA-3-ACID ETHYL ESTERS | Bryant Ranch Prepack | 2022-01-10 |
| 71335-2024-05 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (71335-2024-5) | OMEGA-3-ACID ETHYL ESTERS | Bryant Ranch Prepack | 2022-01-10 |
| 71335-2024-06 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (71335-2024-6) | OMEGA-3-ACID ETHYL ESTERS | Bryant Ranch Prepack | 2022-01-10 |
| 72162-1310-02 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (72162-1310-2) | Omega-3-acid ethyl esters | Bryant Ranch Prepack | 2023-10-06 |
| 72865-0139-05 | 500 CAPSULE, LIQUID FILLED in 1 BOTTLE (72865-139-05) | Omega-3-acid ethyl esters | XLCare Pharmaceuticals, Inc. | 2020-02-17 |
| 72865-0139-12 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (72865-139-12) | Omega-3-acid ethyl esters | XLCare Pharmaceuticals, Inc. | 2020-02-17 |
| 72998-0850-12 | 120 CAPSULE in 1 BOTTLE, PLASTIC (72998-850-12) | OMEGA-3-ACID ETHYL ESTERS | KD Pharma USA, Inc. | 2021-05-01 |
| 72998-0851-12 | 120 CAPSULE in 1 BOTTLE, PLASTIC (72998-851-12) | Omega-3-Acid Ethyl Esters | KD Pharma USA, Inc. | 2024-02-01 |
| 80725-0420-12 | 120 CAPSULE in 1 BOTTLE, PLASTIC (80725-420-12) | Lovaza | Waylis Therapeutics LLC | 2025-01-15 |
Observed labelers:
Bryant Ranch Prepack (8) ·
A-S Medication Solutions (5) ·
Bionpharma Inc. (2) ·
Camber Pharmaceuticals, Inc. (2) ·
KD Pharma USA, Inc. (2) ·
REMEDYREPACK INC. (2)
· +12 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.